01 8Iclusig
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 278
2018 Revenue in Millions : 582
Growth (%) : -52
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 334
2019 Revenue in Millions : 284
Growth (%) : 18
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 45
2020 Revenue in Millions : 38
Growth (%) : 26
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 292
2020 Revenue in Millions : 320
Growth (%) : -2
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 48
2021 Revenue in Millions : 45
Growth (%) : 8
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 338
2021 Revenue in Millions : 292
Growth (%) : 16
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 363
2022 Revenue in Millions : 337
Growth (%) : 22
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 47
2022 Revenue in Millions : 48
Growth (%) : 9
LOOKING FOR A SUPPLIER?